228 related articles for article (PubMed ID: 23025025)
21. Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding.
Struijk M; Postma DF; van Tuyl SA; van de Ree MA
Eur J Intern Med; 2012 Apr; 23(3):227-30. PubMed ID: 22385878
[TBL] [Abstract][Full Text] [Related]
22. Re: Sørensen et al.: low dose aspirin.
Petroski D
Am J Gastroenterol; 2001 May; 96(5):1646. PubMed ID: 11374720
[No Abstract] [Full Text] [Related]
23. Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.
Lin KJ; De Caterina R; García Rodríguez LA
Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):70-7. PubMed ID: 24254886
[TBL] [Abstract][Full Text] [Related]
24. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Morimoto T; Fukui T; Lee TH; Matsui K
Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
26. When it comes to aspirin, men and women are not equal: aspirin acts differently in women.
Sofer D
Am J Nurs; 2005 Jun; 105(6):20. PubMed ID: 15930857
[No Abstract] [Full Text] [Related]
27. Aspirin: real benefits, but real risks, too.
Harv Heart Lett; 1999 May; 9(9):1-3. PubMed ID: 10200029
[No Abstract] [Full Text] [Related]
28. Population and individual health: the two faces of Janus.
Goodyear-Smith F
J Prim Health Care; 2010 Jun; 2(2):90-1. PubMed ID: 20690296
[No Abstract] [Full Text] [Related]
29. Update on aspirin. People with heart disease should take aspirin; the decision is trickier for those without it.
Harv Heart Lett; 2011 Aug; 21(12):3. PubMed ID: 21991607
[No Abstract] [Full Text] [Related]
30. Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study.
Welin L; Wilhelmsen L; Björnberg A; Odén A
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1143-9. PubMed ID: 19672841
[TBL] [Abstract][Full Text] [Related]
31. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
32. [Acetylsalicylic acid and gastrointestinal hemorrhages: preferably a lower dosage].
Tytgat GN; Vreeburg EM; van der Meer J
Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2219-23. PubMed ID: 8984364
[No Abstract] [Full Text] [Related]
33. Tighter aspirin control urged for patients with diabetes. Taking aspirin increases bleeding risk that is not always outweighed by the potential benefits for patients with low cardiovascular disease risk.
Heart Advis; 2010 Aug; 13(8):6. PubMed ID: 22792576
[No Abstract] [Full Text] [Related]
34. Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel.
Alli O; Smith C; Hoffman M; Amanullah S; Katz P; Amanullah AM
J Clin Gastroenterol; 2011; 45(5):410-4. PubMed ID: 20975574
[TBL] [Abstract][Full Text] [Related]
35. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
Rodondi N; Bauer DC
Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
[No Abstract] [Full Text] [Related]
36. A Balanced View of Efficacy and Safety of Aspirin in Cardiovascular Diseases.
Casado-Arroyo R; Lanas A; Brugada P
Curr Pharm Des; 2015; 21(35):5101-7. PubMed ID: 26369681
[TBL] [Abstract][Full Text] [Related]
37. Aspirin therapy in diabetes mellitus.
Colwell JA
Diabetologia; 1997 Jul; 40(7):867. PubMed ID: 9243111
[No Abstract] [Full Text] [Related]
38. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
Gellatly RM; Ackman ML
Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
[TBL] [Abstract][Full Text] [Related]
39. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
Spinler SA
Pharmacotherapy; 2009 Jul; 29(7):812-21. PubMed ID: 19558255
[TBL] [Abstract][Full Text] [Related]
40. Association of aspirin use with major bleeding in patients with and without diabetes.
De Berardis G; Lucisano G; D'Ettorre A; Pellegrini F; Lepore V; Tognoni G; Nicolucci A
JAMA; 2012 Jun; 307(21):2286-94. PubMed ID: 22706834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
